I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 27% ± 9% | |
| GABAergic neuron | 3 studies | 24% ± 1% | |
| glutamatergic neuron | 3 studies | 33% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 27% ± 9% | |
| GABAergic neuron | 3 studies | 24% ± 1% | |
| glutamatergic neuron | 3 studies | 33% ± 5% |
Insufficient scRNA-seq data for expression of MYNN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 970.00 | 21 / 21 | 100% | 10.25 | 504 / 504 |
| breast | 100% | 1100.13 | 459 / 459 | 100% | 13.65 | 1118 / 1118 |
| esophagus | 100% | 897.13 | 1445 / 1445 | 100% | 13.94 | 183 / 183 |
| lung | 100% | 877.65 | 578 / 578 | 100% | 14.90 | 1155 / 1155 |
| ovary | 100% | 1166.54 | 180 / 180 | 100% | 14.52 | 430 / 430 |
| uterus | 100% | 1208.65 | 170 / 170 | 100% | 15.14 | 459 / 459 |
| prostate | 100% | 931.51 | 245 / 245 | 100% | 9.93 | 501 / 502 |
| brain | 100% | 629.32 | 2634 / 2642 | 100% | 11.35 | 705 / 705 |
| stomach | 100% | 802.43 | 359 / 359 | 100% | 9.24 | 285 / 286 |
| liver | 100% | 532.95 | 226 / 226 | 100% | 5.91 | 404 / 406 |
| pancreas | 100% | 611.28 | 328 / 328 | 99% | 8.49 | 177 / 178 |
| thymus | 100% | 1000.63 | 653 / 653 | 99% | 9.14 | 601 / 605 |
| kidney | 100% | 674.28 | 89 / 89 | 99% | 8.89 | 891 / 901 |
| intestine | 100% | 909.60 | 966 / 966 | 99% | 8.77 | 521 / 527 |
| adrenal gland | 100% | 730.68 | 258 / 258 | 98% | 5.64 | 226 / 230 |
| skin | 100% | 1007.23 | 1809 / 1809 | 90% | 7.43 | 426 / 472 |
| blood vessel | 100% | 881.59 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 9.01 | 29 / 29 |
| muscle | 100% | 814.46 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 961.10 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 16.43 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.22 | 1 / 1 |
| adipose | 100% | 1086.81 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 580.77 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 90% | 576.85 | 840 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 56% | 2.50 | 45 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | MYNN |
| Protein name | Myoneurin MYNN protein Myoneurin (Zinc finger and BTB domain-containing protein 31) |
| Synonyms | SBBIZ1 OSZF ZBTB31 |
| Description | |
| Accessions | Q9NPC7 ENST00000602751.5 [Q9NPC7-4] Q05CW1 ENST00000544106.5 [Q9NPC7-2] ENST00000356716.8 [Q9NPC7-1] ENST00000602391.1 ENST00000349841.10 [Q9NPC7-1] R4GMT1 |
